Biohit Oyj (HEL:BIOBV)
2.680
-0.020 (-0.74%)
Aug 7, 2026, 5:26 PM EET
Biohit Oyj Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.6 | 3.54 | 3.75 | 3.27 | 2.12 | 1.1 |
Cash & Short-Term Investments | 1.6 | 3.54 | 3.75 | 3.27 | 2.12 | 1.1 |
Cash Growth | -54.78% | -5.53% | 14.49% | 54.15% | 92.56% | 6.17% |
Accounts Receivable | 2.8 | 3.6 | 3.21 | 4.13 | 2.75 | 2.72 |
Inventory | 0.7 | 0.8 | 1.03 | 0.89 | 0.92 | 0.75 |
Other Current Assets | 2.2 | 1.31 | 2.96 | 3.54 | 4.11 | 4.41 |
Total Current Assets | 7.4 | 9.25 | 10.95 | 11.83 | 9.9 | 8.99 |
Net Property, Plant & Equipment | 1.9 | 1.86 | 0.7 | 0.77 | 0.99 | 0.42 |
Other Intangible Assets | 0.9 | 0.71 | 0.49 | 0.18 | 0.04 | 0.14 |
Other Long-Term Assets | 10.2 | 7.99 | 3.36 | 0.14 | 0.08 | 0.07 |
Total Assets | 20.6 | 19.81 | 15.5 | 12.92 | 11.02 | 9.61 |
Accounts Payable | 0.7 | 1.04 | 0.68 | 0.47 | 0.68 | 0.58 |
Accrued Expenses | - | 1.4 | 1.61 | 1.95 | - | - |
Short-Term Debt | - | - | - | - | 0.26 | 0.07 |
Current Portion of Leases | 0.3 | 0.34 | 0.3 | 0.28 | - | - |
Other Current Liabilities | 2.2 | 0.84 | 0.42 | 0.37 | 1.93 | 1.5 |
Total Current Liabilities | 3.2 | 3.61 | 3.02 | 3.06 | 2.86 | 2.15 |
Long-Term Leases | 1.1 | 1.25 | 0.28 | 0.43 | 0.69 | 0.16 |
Other Long-Term Liabilities | - | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Long-Term Liabilities | 1.1 | 1.26 | 0.29 | 0.44 | 0.7 | 0.16 |
Total Liabilities | 4.3 | 4.87 | 3.31 | 3.5 | 3.56 | 2.31 |
Common Stock | 2.4 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 |
Additional Paid-in Capital | 5.3 | 5.29 | 5.27 | 5.21 | 5.14 | 5.14 |
Accumulated Other Comprehensive Income | -2 | -2 | -1.97 | -1.97 | -1.81 | -1.17 |
Retained Earnings | 10.6 | 9.3 | 6.53 | 3.84 | 1.78 | 0.98 |
Shareholders' Equity | 16.2 | 14.94 | 12.19 | 9.43 | 7.46 | 7.3 |
Total Liabilities & Equity | 20.6 | 19.81 | 15.5 | 12.92 | 11.02 | 9.61 |
Total Debt | 1.4 | 1.59 | 0.59 | 0.7 | 0.94 | 0.22 |
Net Cash (Debt) | 0.2 | 1.95 | 3.16 | 2.57 | 1.18 | 0.88 |
Net Cash Growth | -89.74% | -38.25% | 22.93% | 117.90% | 33.83% | 34.09% |
Net Cash Per Share | 0.01 | 0.13 | 0.21 | 0.17 | 0.08 | 0.06 |
Book Value | 16.2 | 14.94 | 12.19 | 9.43 | 7.46 | 7.3 |
Book Value Per Share | 1.07 | 0.97 | 0.80 | 0.62 | 0.50 | 0.49 |
Tangible Book Value | 15.3 | 14.23 | 11.7 | 9.24 | 7.42 | 7.16 |
Tangible Book Value Per Share | 1.01 | 0.93 | 0.77 | 0.61 | 0.49 | 0.48 |